Resources
Filter by Topic
- Articles
Joseph Menzin, PhD, discusses the risks and rewards of fast-tracked COVID-19 studies.
- Press Releases
BHE, a leading healthcare analytics company, has announced the formation of its Strategic Advisory Board. The initial appointments include Peter Neumann, ScD, Director of the...
- Articles
Matthew Sussman, BHE's VP of Modeling & Strategy Services, discusses the use of remdesivir for COVID-19 patients and the risks and rewards of fast tracking...
- News & Events
Matthew Sussman, BHE's VP of Modeling & Strategy Services, discusses exploring strategies for facilitating access to the timely patient data and analysis needed for successful...
- News & Events
We formed a partnership with Premier Inc. to streamline data analytics and more quickly uncover strategies to improve patient care. Researchers and data scientists will...
- Press Releases
Boston Health Economics (BHE), a leading healthcare self-service analytics company, and Premier Healthcare Solutions, Inc. (Premier), a leading healthcare improvement company, are joining forces to...
- Articles
Healthcare IT Today article from Panalgo Founder and Executive Chairman, Joseph Menzin, PhD.
Gaining Rapid Understanding of COVID-19 Through a Real-world Data Lens
In this Healthcare IT Today article, Joseph Menzin, PhD, dives into the COVID-19 pandemic and the need for more timely data in the course of
The Future of Healthcare: “We need to recognize that health outcomes are not just about medical care”, With Dr. Joseph Menzin of Boston Health Economics
Panalgo CEO, Joseph Menzin, PhD, gets interviewed as a leader in the healthcare industry. Joe talks the founding of BHE and his 30 years of
Life science companies combine to form COVID-19 research database
Click here to read the article.
Leading Healthcare Companies Announce COVID-19 Research Database
A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database, a secure repository of HIPAA-compliant, de-identified and limited patient-level data
ICER’s Development and Use of RWE: 5 Areas for Concern
The pervasiveness of real-world data (RWD) and the need to understand outcomes in clinical practice have galvanized the ubiquity and utility of real-world evidence (RWE).
Estimated Lifetime Economic Burden of Type 1 Diabetes
Authors: Matthew Sussman, Jennifer Benner, Dr. Michael Haller, Dr. Marian Rewers, Dr. Robert Griffiths Published: Diabetes Technology & Therapeutics Click here to view the article.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization